Helvaci Yilmaz Nesrin, Polat Burcu, Hanoglu Lutfu
Department of Neurology, Faculty of Medicine, Istanbul Medipol University, Faculty of Medicine, Istanbul, Turkey.
Neurologist. 2016 Mar;21(2):28-9. doi: 10.1097/NRL.0000000000000070.
Pharmacotherapy and thalamic stimulation are the most accepted methods used for the treatment of essential tremor (ET). Transcranial direct current stimulation (tDCS) is a noninvasive method for brain stimulation, especially to treat pain, cerebrovascular disease, and depression. tDCS applied to the cerebellar region has been shown to exhibit a modulating effect on the excitability of Purkinje cells and to cause primary motor cortex inhibition through the regulation of synaptic dentato-thalamo-cortical excitability. There is only 1 trial that studied the effect of tDCS on ET with 8 patients, and the results were not satisfactory.
Six ET patients were administered the Essential Tremor Rating Assessment Scale (TETRAS) and Activities of Daily Living (ADL). We applied tDCS to the dorsolateral prefrontal areas (anode) and to inion (inion at 2 mA for 20 min in 10 consecutive sessions with a 2-d break between the first and the second 5-d sessions). One month after the initial course of therapy, 5 more tDCS sessions were administered in an every-other-day manner. TETRAS and ADL scales were readministered. The Friedman test was used to assess differences in TETRAS scores and ADL over the whole time course.
A significant improvement was observed in TETRAS and ADL scores at the end of 50 days (P=0.015, 0.024). We concluded that although our sample group is small, tDCS might be an alternative therapy for patients with ET.
药物治疗和丘脑刺激是治疗特发性震颤(ET)最常用的方法。经颅直流电刺激(tDCS)是一种非侵入性脑刺激方法,尤其用于治疗疼痛、脑血管疾病和抑郁症。已证明,将tDCS应用于小脑区域可对浦肯野细胞的兴奋性产生调节作用,并通过调节突触齿状核-丘脑-皮质兴奋性导致初级运动皮层抑制。仅有一项试验研究了tDCS对8例ET患者的影响,结果并不理想。
对6例ET患者进行了特发性震颤评分评估量表(TETRAS)和日常生活活动能力(ADL)评估。我们将tDCS应用于背外侧前额叶区域(阳极)和枕外隆凸(枕外隆凸,2 mA,持续20分钟,连续10次,在第一个和第二个5天疗程之间休息2天)。在初始疗程1个月后,每隔一天进行5次tDCS治疗。再次进行TETRAS和ADL量表评估。采用Friedman检验评估整个疗程中TETRAS评分和ADL的差异。
在50天结束时,TETRAS和ADL评分有显著改善(P = 0.015,0.024)。我们得出结论,尽管我们的样本量较小,但tDCS可能是ET患者的一种替代治疗方法。